Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Treatment for HIV-Positive Patients with Fever and Bacterial Infection

Initial Management Approach

  • An HIV-positive patient with fever and bacterial infection who has run out of antivirals should immediately receive empiric antibiotic therapy with a beta-lactam plus a macrolide, while urgent efforts are made to restart antiretroviral therapy, as recommended by the Centers for Disease Control and Prevention (CDC) 1
  • Assess disease severity and oxygenation status to determine if outpatient or inpatient management is appropriate, according to the CDC 1
  • Collect specimens for microbiologic studies before initiating antibiotics, but do not delay antibiotic therapy while waiting for results, as advised by the CDC 1

Antibiotic Selection

  • Administer an oral beta-lactam plus an oral macrolide for outpatient treatment, with preferred beta-lactams being high-dose amoxicillin or amoxicillin-clavulanate, and preferred macrolides being azithromycin or clarithromycin, as recommended by the CDC 1
  • For inpatient treatment, administer an IV beta-lactam plus a macrolide, with preferred beta-lactams being ceftriaxone, cefotaxime, or ampicillin-sulbactam, according to the CDC 1
  • For severe illness requiring ICU, administer an IV beta-lactam plus either IV azithromycin or an IV respiratory fluoroquinolone, as recommended by the CDC 1

Important Considerations

  • Never use macrolide monotherapy due to increased risk of drug-resistant Streptococcus pneumoniae in HIV-infected patients, as warned by the CDC 1
  • Use fluoroquinolones with caution when tuberculosis is suspected, as they may mask TB symptoms and delay diagnosis, according to the CDC 1
  • For patients with Salmonella gastroenteritis, consider ciprofloxacin (750 mg twice daily for 14 days) to prevent extraintestinal spread, as recommended by the CDC 2
  • HIV-infected patients with Salmonella septicemia require long-term therapy to prevent recurrence, usually with a fluoroquinolone for susceptible organisms, as advised by the CDC 2

Prophylaxis Considerations

  • Initiate or restart TMP-SMZ for PCP prophylaxis if CD4 count is <200 cells/mm³ or unknown, as recommended by the CDC 3
  • TMP-SMZ prophylaxis may also help prevent bacterial respiratory infections, according to the CDC 1
  • Consider pneumococcal vaccination if not administered within the past 5 years, as recommended by the CDC 3

Follow-up

  • Ensure prompt reengagement with HIV care and resumption of antiretroviral therapy, as recommended by the CDC 4
  • Test bacterial isolates for antimicrobial susceptibility, particularly for S. pneumoniae and H. influenzae, as advised by the CDC 5
  • Adjust antibiotic therapy based on culture results and clinical response, according to the CDC 1